Monopar Therapeutics (MNPR) PT Raised to $128 at Barclays
Tweet
Share
E-mailGet Alerts MNPR Hot Sheet
Price: $113.84 -0.47%
Rating Summary:
14 Buy, 2 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Rating Summary:
14 Buy, 2 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Join SI Premium – FREE
Barclays analyst Etzer Darout raised the price target on Monopar Therapeutics (NASDAQ: MNPR) to $128.00 (from $125.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Macquarie Downgrades Mercari, Inc (4385:JP) (MRCIF) to Neutral
- KIOXIA Holdings (285A:JP) PT Raised to JPY131,000 at Nomura/Instinet
- Tokyo Ohka Kogyo Co., Ltd (4186:JP) (TOKCF) PT Lowered to JPY9,500 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
